Coding region polymorphisms in T cell signal transduction genes. Prevalence and association to development of multiple sclerosis

Journal of Neuroimmunology

Volumn 177, Issue 1-2, 2006, Pages 40-45

  Harbo, Hanne F ^a,b   Ekstrøm, Per O ^c   Lorentzen, Åslaug R ^a   Sundvold Gjerstad, Vibeke ^a   Celius, Elisabeth G ^b   Sawcer, Stephen ^a,d   Spurkland, Anne ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

DCE; Genetic susceptibility; Multiple sclerosis; PTPN22; T cell signal transduction genes

Indexed keywords

DNA; PROTEIN; PROTEIN PLCG1; PROTEIN PTPN22; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MULTIPLE SCLEROSIS; NORMAL HUMAN; NORWAY; PREVALENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

EID: 33746291562     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.04.021     Document Type: Article

References (39)

1. Barratt B.J., Payne F., Rance H.E., Nutland S., Todd J.A., and Clayton D.G. Identification of the sources of error in allele frequency estimations from pooled DNA indicates an optimal experimental design. Ann. Hum. Genet. 66 (2002) 393-405
2. Begovich A.B., Caillier S.J., Alexander H.C., Penko J.M., Hauser S.L., Barcellos L.F., and Oksenberg J.R. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am. J. Hum. Genet. 76 (2005) 184-187
3. Bonin A., Bellemain E., Bronken E.P., Pompanon F., Brochmann C., and Taberlet P. How to track and assess genotyping errors in population genetics studies. Mol. Ecol. 13 (2004) 3261-3273
4. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., MacMurray J., Meloni G.F., Lucarelli P., Pellecchia M., Eisenbarth G.S., Comings D., and Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36 (2004) 337-338
5. Brzustowicz L.M., Merette C., Xie X., Townsend L., Gilliam T.C., and Ott J. Molecular and statistical approaches to the detection and correction of errors in genotype databases. Am. J. Hum. Genet. 53 (1993) 1137-1145
6. Compston A., and Coles A. Multiple sclerosis. Lancet 359 (2002) 1221-1231
7. Compston D.A., Batchelor J.R., and McDonald W.I. B-lymphocyte alloantigens associated with multiple sclerosis. Lancet 2 (1976) 1261-1265
8. Criswell L.A., Pfeiffer K.A., Lum R.F., Gonzales B., Novitzke J., Kern M., Moser K.L., Begovich A.B., Carlton V.E., Li W., Lee A.T., Ortmann W., Behrens T.W., and Gregersen P.K. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet. 76 (2005) 561-571
9. Dai K.Z., Harbo H.F., Celius E.G., Oturai A., Sorensen P.S., Ryder L.P., Datta P., Svejgaard A., Hillert J., Fredrikson S., Sandberg-Wollheim M., Laaksonen M., Myhr K.M., Nyland H., Vartdal F., and Spurkland A. The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun. 2 (2001) 263-268
10. Darimont J., Grosch S., Skarke C., Geisslinger G., and Lotsch J. Comparison of two screening methods for in-house genotyping in clinical pharmacology units. Int. J. Clin. Pharmacol. Ther. 43 (2005) 17-22
11. Dyment D.A., Steckley J.L., Willer C.J., Armstrong H., Sadovnick A.D., Risch N., and Ebers G.C. No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study. J. Neuroimmunol. 123 (2002) 193-198
12. Dyment D.A., Ebers G.C., and Sadovnick A.D. Genetics of multiple sclerosis. Lancet Neurol. 3 (2004) 104-110
13. Dyment D.A., Steckley J.L., Morrison K., Willer C.J., Cader M.Z., DeLuca G.C., Sadovnick A.D., Risch N., and Ebers G.C. TCR beta polymorphisms and multiple sclerosis. Genes Immun. 5 (2004) 337-342
14. Dyment D.A., Herrera B.M., Cader M.Z., Willer C.J., Lincoln M.R., Sadovnick A.D., Risch N., and Ebers G.C. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum. Mol. Genet. 14 (2005) 2019-2026
15. Ekstrom P.O., Bjorheim J., Gaudernack G., and Giercksky K.E. Population screening of single-nucleotide polymorphisms exemplified by analysis of 8000 alleles. J. Biomol. Screen. 7 (2002) 501-506
16. Fischer S.G., and Lerman L.S. DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 1579-1583
17. International Multiple Sclerosis Genetics Consortium. A high-density screen for linkage in multiple sclerosis. Am. J. Hum. Genet. 77 (2005) 454-467
18. Jersild C., Svejgaard A., and Fog T. HL-A antigens and multiple sclerosis. Lancet 1 (1972) 1240-1241
19. Knight J.C. Regulatory polymorphisms underlying complex disease traits. J. Mol. Med. 83 (2005) 97-109
20. Kristensen A.T., Bjorheim J., Wiig J., Giercksky K.E., and Ekstrom P.O. DNA variants in the ATM gene are not associated with sporadic rectal cancer in a Norwegian population-based study. Int. J. Colorectal Dis. 19 (2004) 49-54
21. Kristiansen O.P., Larsen Z.M., and Pociot F. CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity?. Genes Immun. 1 (2000) 170-184
22. Kyogoku C., Langefeld C.D., Ortmann W.A., Lee A., Selby S., Carlton V.E., Chang M., Ramos P., Baechler E.C., Batliwalla F.M., Novitzke J., Williams A.H., Gillett C., Rodine P., Graham R.R., Ardlie K.G., Gaffney P.M., Moser K.L., Petri M., Begovich A.B., Gregersen P.K., and Behrens T.W. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 75 (2004) 504-507
23. Lorentzen A.R., Celius E.G., Ekstrom P.O., Wiencke K., Lie B.A., Myhr K.M., Ling V., Thorsby E., Vartdal F., Spurkland A., and Harbo H.F. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients. J. Neuroimmunol. 166 (2005) 197-201
24. Matesanz F., Rueda B., Orozco G., Fernandez O., Leyva L., Alcina A., and Martin J. Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis. J. Neurol. (2005)
25. Oksenberg J.R., and Barcellos L.F. Multiple sclerosis genetics: leaving no stone unturned. Genes Immun. 6 (2005) 375-387
26. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., and Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Intern. Med. J. 13 (1983) 227-231
27. Roxburgh R.H., Sawcer S., Maranian M., Seaman S., Hensiek A., Yeo T., Deans J., and Compston A. No evidence of a significant role for CTLA-4 in multiple sclerosis. J. Neuroimmunol. 171 (2006) 193-197
28. Sakaguchi N., Takahashi T., Hata H., Nomura T., Tagami T., Yamazaki S., Sakihama T., Matsutani T., Negishi I., Nakatsuru S., and Sakaguchi S. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426 (2003) 454-460
29. Sawcer S., and Compston A. The genetic analysis of multiple sclerosis in Europeans: concepts and design. J. Neuroimmunol. 143 (2003) 13-16
30. Seboun E., Robinson M.A., Doolittle T.H., Ciulla T.A., Kindt T.J., and Hauser S.L. A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell 57 (1989) 1095-1100
31. Setakis E. Statistical analysis of the GAMES studies. J. Neuroimmunol. 143 (2003) 47-52
32. Smerdel A., Dai K.Z., Lorentzen A.R., Flato B., Maslinski S., Thorsby E., Forre O., and Spurkland A. Genetic association between juvenile rheumatoid arthritis and polymorphism in the SH2D2A gene. Genes Immun. 5 (2004) 310-312
33. *G haplotype is associated with susceptibility to multiple sclerosis in Flanders. J. Neuroimmunol. 164 (2005) 148-153
34. Teutsch S.M., Booth D.R., Bennetts B.H., Heard R.N., and Stewart G.J. Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients. J. Neuroimmunol. 148 (2004) 218-230
35. The Transatlantic Multiple Sclerosis Genetics Cooperative. A meta-analysis of genomic screens in multiple sclerosis. Mult. Scler. 7 (2001) 3-11
36. The Transatlantic Multiple Sclerosis Genetics Cooperative. A meta-analysis of whole genome linkage screens in multiple sclerosis. J. Neuroimmunol. 143 (2003) 39-46
37. Viken M.K., Amundsen S.S., Kvien T.K., Boberg K.M., Gilboe I.M., Lilleby V., Sollid L.M., Forre O.T., Thorsby E., Smerdel A., and Lie B.A. Association analysis of the 1858C > T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun. 6 (2005) 271-273
38. Winchester R., Ebers G., Fu S.M., Espinosa L., Zabriskie J., and Kunkel H.G. B-cell alloantigen Ag 7a in multiple sclerosis. Lancet 2 (1975) 814
39. Yokoi N., Komeda K., Wang H.Y., Yano H., Kitada K., Saitoh Y., Seino Y., Yasuda K., Serikawa T., and Seino S. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat. Genet. 31 (2002) 391-394